Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to $92.0 million.

  • Definitive Healthcare's Current Deferred Revenue rose 668.65% to $92.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.0 million, marking a year-over-year increase of 668.65%. This contributed to the annual value of $93.3 million for FY2024, which is 414.16% down from last year.
  • Latest data reveals that Definitive Healthcare reported Current Deferred Revenue of $92.0 million as of Q3 2025, which was up 668.65% from $100.9 million recorded in Q2 2025.
  • Over the past 5 years, Definitive Healthcare's Current Deferred Revenue peaked at $109.7 million during Q1 2025, and registered a low of $69.8 million during Q3 2021.
  • Over the past 5 years, Definitive Healthcare's median Current Deferred Revenue value was $93.6 million (recorded in 2022), while the average stood at $93.9 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first skyrocketed by 3693.25% in 2021, then tumbled by 414.16% in 2024.
  • Over the past 5 years, Definitive Healthcare's Current Deferred Revenue (Quarter) stood at $83.6 million in 2021, then increased by 19.23% to $99.7 million in 2022, then dropped by 2.32% to $97.4 million in 2023, then decreased by 4.14% to $93.3 million in 2024, then decreased by 1.46% to $92.0 million in 2025.
  • Its Current Deferred Revenue stands at $92.0 million for Q3 2025, versus $100.9 million for Q2 2025 and $109.7 million for Q1 2025.